USA flag logo/image

An Official Website of the United States Government

OBLIQUELY DEPOSITED SUBSTRATES FOR DETECTION OF RAS

Award Information

Agency:
Department of Health and Human Services
Branch:
N/A
Award ID:
59868
Program Year/Program:
2002 / SBIR
Agency Tracking Number:
CA096052
Solicitation Year:
N/A
Solicitation Topic Code:
N/A
Solicitation Number:
N/A
Small Business Information
PLATYPUS TECHNOLOGIES, LLC
5520 Nobel Drive Suite 100 Madison, WI 53711-4910
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 1
Fiscal Year: 2002
Title: OBLIQUELY DEPOSITED SUBSTRATES FOR DETECTION OF RAS
Agency: HHS
Contract: 1R43CA096052-01
Award Amount: $294,115.00
 

Abstract:

Key cell signaling molecules, such as Ras, play a central role in carcinogenesis and are the targets for a new generation of drugs that inhibit protein kinases. The ability to measure the activation status of molecules along an entire pathway is of increasing importance, yet the available technologies are inadequate to handle the demand for simple assays that permit simultaneous testing of several molecules and can determine their total concentration, activation status, and post- translational modifications, such as phosphorylation or farnesylation. The movement of protein kinase inhibitors and related compounds into clinical trials will increase the demand for such assays in academic, pharmaceutical and clinical laboratories. Platypus technology is a novel, broadly applicable platform nanotechnology based on the sensitivity of liquid crystals to nanoscale features in surfaces. The technology permits highly sensitive detection of molecular interactions and is adaptable to automated and multiplexed formats. In this proposal, we will optimize the technology for the detection and quantification of total Ras and activated Ras, utilizing gold films with anisotropic topography. PROPOSED COMMERCIAL APPLICATIONS: Platypus Technology is a revolutionary platform technology with broad application potential. A rapid method for the analysis of total and activated Ras will have a large market and form the basis of a device to measure multiple molecules along a signaling pathway, determine their amounts and the relative portion of activation.

Principal Investigator:

Barbara A. Israel
6084412776
BISRAEL@PLATYPUSTECH.COM

Business Contact:

Christopher Murphy
6082652454
MURPHYC@SVM.VETMED.WISC.EDU
Small Business Information at Submission:

PLATYPUS TECHNOLOGIES, LLC
PLATYPUS TECHNOLOGIES, LLC 505 S ROSA RD MADISON, WI 53719

EIN/Tax ID: 391992935
DUNS: N/A
Number of Employees: N/A
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No